On 17 May 2021, the Acting Administrator of the Health Resources and Services Administration (HRSA), Diana Espinosa, sent letters to six pharmaceutical manufacturers stating that the manufacturers’ ...
A federal court in Delaware recently determined that the Health Resources and Services Administration (HRSA) – the federal agency responsible for administering the 340B drug pricing program – did not ...
WASHINGTON, December 16, 2024--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) welcomes the U.S. Health Resources and Services Administration move against Sanofi’s attack on the 340B Drug Pricing ...
A new court filing from Eli Lilly shows that drug companies will likely fight the Biden administration's penalties for not selling 340B drugs to contract pharmacies. (Eli Lilly) () Eli Lilly is asking ...
Eli Lilly is restricting access to a drug discount program for safety-net hospitals in a move it says is needed to identify ...
The Biden administration must withdraw a warning to drugmaker AstraZeneca over its access restrictions on 340B contract pharmacies, according to the latest ruling in a legal feud between the ...
Although not “contrary to law, unconstitutional or violative of notice and process procedures,” a May 17 enforcement letter HHS’ Health Resources and Services Administration (HRSA) sent to Eli Lilly ...
The Biden administration is threatening Johnson & Johnson with fines if the drugmaker follows through with planned changes to how it offers hospitals savings on two widely prescribed drugs in the 340B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results